Advance Search
CHEN Lingzhi, ZHONG Kaiyi, CHEN Liguo. Expression and clinical significance of serum adiponectin and secretory melanoma cell adhesion molecule in type 2 diabetic nephropathy[J]. Journal of Clinical Medicine in Practice, 2023, 27(2): 13-16. DOI: 10.7619/jcmp.20222051
Citation: CHEN Lingzhi, ZHONG Kaiyi, CHEN Liguo. Expression and clinical significance of serum adiponectin and secretory melanoma cell adhesion molecule in type 2 diabetic nephropathy[J]. Journal of Clinical Medicine in Practice, 2023, 27(2): 13-16. DOI: 10.7619/jcmp.20222051
shu

Expression and clinical significance of serum adiponectin and secretory melanoma cell adhesion molecule in type 2 diabetic nephropathy

  • Department of Nephrology, Hainan West Central Hospital, Danzhou, Hainan, 571700

More Information
  • Received Date: July 02, 2022
  • Available Online: February 15, 2023
    Graphical Abstract
    • Abstract
  • Objective 

    To investigate the expressions and clinical significance of adiponectin(ADPN)and secretory melanoma cell adhesion molecule(MCAM)in patients with type 2 diabetic nephropathy(T2DN).

    Methods 

    A total of 180 T2DN patients admitted to Hainan West Central Hospital from June 2020 to June 2021 were selected as T2DN group. According to the urinary albumin excretion rate (UAER), the patients in the T2DN group weredivided into mild group (n=52), moderate group (n=66) and severe group (n=62). Fifty-eight healthy subjects with normal physical examinations were selected as control group, the differences of ADPN and MCAM in T2DN patients with different degrees of disease were compared, and the receiver operating characteristic (ROC) curve was used to analyze the clinical efficacy of serum ADPN and secreted MCAM in the diagnosis of T2DN.

    Results 

    The expression level of serum ADPN in T2DN group was (10.67±1.21) μg/mL, which was lower than (12.36±3.08) μg/mL in control group, and the expression level of secreted MCAM was (118.89±26.07) μg/L, which was higher than (68.79±18.34) μg/L that in control group, the differences were statistically significant (P < 0.05). The serum ADPN levels in the moderate group and severe group were lower than those in the mild group, the ADPN level in the severe group was lower than that in moderate group, the secretory MCAM levels in the moderate group and severe group were higher than that in mild group, and the MCAM level in the severe group was higher than that in moderate group, the differences were statistically significant (P < 0.05). ROC curve showed that the area under the curve (AUC), sensitivity and specificity of serum ADPN and secretory MCAM in diagnosis of T2DN were higher than those of serum ADPN and secretory MCAM alone (Z=2.223, 2.344, P < 0.05).

    Conclusion 

    Serum ADPN and secretory MCAM may be used as indicators for T2DN diagnosis and disease assessment, and the combined detection can improve the diagnosis rate of T2DN.

    • FullText(HTML)
    • References (15)
  • [1]
    张乃莹, 黎波. 2型糖尿病相关血清生物标志物检测分析[J]. 实用临床医药杂志, 2020, 24(21): 79-81. doi: 10.7619/jcmp.202021023
    [2]
    CHOI GS, MIN HS, CHA JJ, et al. SH3YL1 protein as a novel biomarker for diabetic nephropathy in type 2 diabetes mellitus[J]. Nutr Metab Cardiovasc Dis, 2021, 31(2): 498-505. doi: 10.1016/j.numecd.2020.09.024
    [3]
    吴恒兰, 朱富祥, 陈建祥, 等. 高糖对人脐静脉内皮细胞表达的黏附分子CD146的影响[J]. 中国中西医结合肾病杂志, 2019, 20(5): 436-438. doi: 10.3969/j.issn.1009-587X.2019.05.020
    [4]
    中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)[J]. 中国实用内科杂志, 2021, 41(9): 757-784. https://www.cnki.com.cn/Article/CJFDTOTAL-HBYX202112018.htm
    [5]
    李志超, 孟钰, 段会然, 等. 单核细胞/高密度脂蛋白比值与2型糖尿病合并下肢动脉硬化闭塞症的相关性分析[J]. 中国动脉硬化杂志, 2020, 28(3): 242-246, 252. doi: 10.3969/j.issn.1007-3949.2020.03.012
    [6]
    刘莉芳, 赵桁, 张云良, 等. 2型糖尿病患者血清Nesfatin-1、HSP60与下肢血管病变的相关性研究[J]. 中国动脉硬化杂志, 2021, 29(11): 965-970. doi: 10.3969/j.issn.1007-3949.2021.11.009
    [7]
    倪晓英, 廖卓君, 冯建勋, 等. 葡糖醛酸基葡糖胺聚糖硫酸盐对糖尿病肾病的干预效果[J]. 实用临床医药杂志, 2021, 25(2): 63-66. doi: 10.7619/jcmp.20200866
    [8]
    贾爱梅, 陈开, 宋永砚. 脂联素基因多态性与冠心病研究进展[J]. 中国动脉硬化杂志, 2020, 28(7): 627-633. https://www.cnki.com.cn/Article/CJFDTOTAL-KDYZ202007015.htm
    [9]
    REN X, ZHANG Z, YAN Z. Association between lipoprotein (A) and diabetic nephropathy in patients with type 2 diabetes mellitus: a meta-analysis[J]. Front Endocrinol: Lausanne, 2021, 12: 633529. doi: 10.3389/fendo.2021.633529
    [10]
    徐丽英, 方豫东, 曹烨民, 等. 血清脂联素、胱抑素C与糖尿病肢体动脉闭塞症的糖脂代谢的关系[J]. 中国医药导报, 2020, 17(1): 98-101. https://www.cnki.com.cn/Article/CJFDTOTAL-YYCY202001025.htm
    [11]
    张铭晖. 糖尿病肾病患者血清脂联素、脂蛋白A和白介素6水平变化及意义[J]. 河北医药, 2019, 41(17): 2642-2645. https://www.cnki.com.cn/Article/CJFDTOTAL-HBYZ201917020.htm
    [12]
    程春生, 李纲. 脂联素、可溶性血管细胞黏附分子-1在不同分期糖尿病肾病患者中的表达及临床意义[J]. 吉林医学, 2017, 38(12): 2274-2275. https://www.cnki.com.cn/Article/CJFDTOTAL-JLYX201712033.htm
    [13]
    赵中, 陈文智, 郑建国, 等. 腹型肥胖2型糖尿病患者血清ADP、Apelin、LIF水平的变化及其意义[J]. 四川医学, 2018, 39(9): 1023-1026. https://www.cnki.com.cn/Article/CJFDTOTAL-SCYX201809016.htm
    [14]
    LIU B, YANG S. Diagnostic Significance of Serum Soluble CD146 Level in Early-stage Diabetic Nephropathy[J]. Journal of China Medical University, 2017, 46(11): 1005-1008.
    [15]
    ABED A, LEROYER A S, KAVVADAS P, et al. Endothelial-specific deletion of CD146 protects against experimental glomerulonephritis in mice[J]. Hypertension, 2021, 77(4): 1260-1272.
    • Related Articles

  • Cited by

    Periodical cited type(24)

    1. 谌洪江. 体检彩超筛查对甲状腺良恶性病变患者的筛查效能分析. 基层医学论坛. 2025(02): 32-35 .
    2. 沈亚珍，范雯，陈志科. 彩色多普勒超声在浅表软组织肿块诊断中的应用价值. 影像研究与医学应用. 2025(02): 46-48 .
    3. 邓淑敏，朱海侠. 彩超血流参数联合血清STK1水平检测对甲状腺结节性质的鉴别诊断价值. 河南医学研究. 2025(03): 456-459 .
    4. 陈香梅. 超声检查对甲状腺结节的诊断价值研究. 影像研究与医学应用. 2025(03): 125-127 .
    5. 孙琦囡，杜磊，段春华. 高频彩色多普勒超声联合US-FNAC在甲状腺癌诊断中的应用价值. 临床和实验医学杂志. 2024(01): 94-97 .
    6. 李传印，崔志英，韩霞，严梦寒. 超声引导下甲状腺细针穿刺检查在甲状腺肿瘤诊断中的应用价值. 临床研究. 2024(03): 126-129 .
    7. 黄晓萍，贺军. 细针抽吸细胞学联合检测BRAF~(V600E)在甲状腺结节诊断中的应用价值. 中国基层医药. 2024(03): 342-346 .
    8. 谭小娇. 心肌酶谱联合肌钙蛋白检测在甲状腺功能减退症诊断中的意义. 智慧健康. 2024(05): 105-108 .
    9. 孙斌，刘长乐，林福建，曾林胜，黄友贞. 25G型细针对彩超引导下富血供甲状腺结节下穿刺标本满意率的影响. 中国当代医药. 2024(12): 57-60 .
    10. 银园精，廖明珍. 彩色多普勒超声对甲状腺结节的临床诊断价值研究. 影像研究与医学应用. 2024(09): 90-92 .
    11. 卢小利，李洲，周勤鹏，卢淑贞，马友良，杨少胜，高建珠，陆燕虹，单艳丽，何光智. 现场快速评估在超声引导下甲状腺结节细针穿刺中的应用价值研究. 影像研究与医学应用. 2024(15): 173-175+178 .
    12. 王明军，薛源，乔楠，乔乐乐，刘九洲，任宁，程维刚. 超声引导下细针穿刺细胞学、鼠类肉瘤病毒癌基因同源物B V600E基因突变单独及联合检测对甲状腺癌的诊断价值. 癌症进展. 2024(17): 1952-1955 .
    13. 赵婷婷. 二维超声联合彩色多普勒超声在甲状腺结节定性诊断中的应用价值及特征分析. 影像研究与医学应用. 2024(20): 35-37 .
    14. 林立龙. 超声引导下甲状腺细针穿刺细胞学检查对甲状腺结节鉴别诊断价值研究. 现代诊断与治疗. 2024(12): 1859-1861 .
    15. 黄星月，袁霄，夏允，吴蕾，刘悌. 彩色多普勒超声用于鉴别甲状腺结节良恶性的价值. 中国辐射卫生. 2024(05): 590-594 .
    16. 郑小蓓. 彩色多普勒超声与二维超声检查在甲状腺良恶性结节中的诊断价值比较. 医药前沿. 2024(14): 48-50 .
    17. 徐树发. 甲状腺TI-RADS分类结合彩超鉴别诊断甲状腺结节良恶性的分析. 中国医疗器械信息. 2024(22): 11-13+103 .
    18. 黄莉，倪圣霞. 彩色多普勒超声、US-FNA以及两者联合应用在甲状腺癌诊断中的价值和临床意义. 影像技术. 2023(04): 68-72 .
    19. 孙明月，董中琴. 超声剪切波弹性成像定量参数鉴别诊断良恶性甲状腺结节的临床价值. 临床研究. 2023(09): 126-129 .
    20. 徐涛. 彩色多普勒超声对甲状腺良恶性结节的诊断效果. 影像研究与医学应用. 2023(20): 168-170 .
    21. 史文利，王康玮，杜洪. 甲状腺细胞学诊断联合基因检测提高甲状腺乳头状癌诊断率. 广州医科大学学报. 2023(06): 18-22 .
    22. 刘文凤，邵婷. 细针穿刺细胞学检查联合C-TI-RADS在临床鉴别诊断良、恶性甲状腺结节中的应用价值. 影像研究与医学应用. 2023(23): 191-193 .
    23. 崔丽娟. 超声引导下细针穿刺抽吸活检鉴别诊断甲状腺结节良恶性的价值. 实用医技杂志. 2023(10): 702-705 .
    24. 程小莉，赵静，张玲铃. 彩色多普勒超声在甲状腺结节良恶性鉴别中的应用价值. 深圳中西医结合杂志. 2023(23): 80-82 .

    Other cited types(1)

Catalog

    Get Citation
    PDF
    XML
    Article views (187) PDF downloads (16) Cited by(25)
    Turn off MathJax
    Article Contents
    Abstract
    References

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return